Literature DB >> 1197143

Hemodynamic changes at rest and during exercise in long-term prazosin therapy for essential hypertension.

P Lund-Johansen.   

Abstract

Fourteen men 30 to 50 years of age (mean, 42) with untreated essential hypertension, WHO stage I or II, and no other demonstrable disease were studied as outpatients. Oxygen consumption, heart rate, cardiac output, and intraarterial brachial pressure were recorded at rest in the supine and sitting positions and during exercise in the form of bicycling. The subjects were then treated with prazosin in a dosage of 3 to 7.5 mg/day. Eleven subjects responded well, and in 10 of these the hemodynamic study was repeated after one year. At the time of restudy, the systolic, diastolic, and mean arterial pressures were reduced about 11% at rest and during exercise. Pressure reduction was associated with a marked decrease in the previously increased total peripheral resistance of about 17% during rest and 22% during exercise. In all but two subjects, total peripheral resistance was reduced 10% or more at rest and during exercise. During exercise, the total peripheral resistance was reduced more than 10% in all subjects. Heart rate and cardiac output were not changed significantly but tended to be higher after one year of therapy. A comparison of the results with those obtained in patients treated with other antihypertensive agents shows that the reduction in total peripheral resistance was greatest in the group receiving prazosin.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1197143

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  5 in total

Review 1.  Antihypertensive drugs: clinical pharmacology and therapeutic use.

Authors:  G L Wollam; R W Gifford; R C Tarazi
Journal:  Drugs       Date:  1977-12       Impact factor: 9.546

2.  Working ability and exercise tolerance during treatment of mild hypertension. II. A comparison between atenolol and prazosin medication.

Authors:  K Lange Andersen; W Ottmann; W Piatkowski; K A Green
Journal:  Int Arch Occup Environ Health       Date:  1985       Impact factor: 3.015

3.  Acute and chronic haemodynamic effects of doxazosin in hypertension at rest and during exercise.

Authors:  P Lund-Johansen; P Omvik; H Haugland
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

Review 4.  The role of multiple action agents in hypertension.

Authors:  P Lund-Johansen; P Omvik
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

5.  Single-dose and steady-state pharmacokinetics of doxazosin given in combination with chlorothiazide to hypertensive subjects.

Authors:  E L Conway; J J McNeil; L Meng; O H Drummer; L G Howes; K Raymond; W J Louis
Journal:  Clin Pharmacokinet       Date:  1989-06       Impact factor: 6.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.